HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With
01 Março 2010 - 4:59PM
PR Newswire (US)
ATLANTA, March 1 /PRNewswire-FirstCall/ -- Hospira, Inc. , a
leading provider of clinical information and medication delivery
technologies, today announced that Memorial Healthcare System (MHS)
was honored as a finalist in the HIMSS (Healthcare Information and
Management Systems Society) inaugural "Stories of Success!
Leveraging HIT, Improving Quality & Safety" program. Memorial
Healthcare System of South Florida, one of 16 applicants selected
for recognition, used Hospira's TheraDoc(TM) clinical surveillance
platform to achieve 97 percent compliance with Joint Commission
pediatric asthma core measures. The case study and TheraDoc
technology will be demonstrated at booth number 6249 at the HIMSS10
conference in Atlanta through March 4. Introduced in October 2009
by HIMSS and the American Society for Quality (ASQ), the Stories of
Success! program called for case studies showcasing real-world
examples of leveraging health information technology to improve
patient safety, quality, effectiveness and efficiency. Memorial
Healthcare System was honored by a peer-review body of experts from
HIMSS, the Joint Commission, the National Committee for Quality
Assurance and the ASQ. The recognized case study highlighted how
MHS' Joe DiMaggio Children's Hospital (JDCH) met the children's
asthma care core measures by using a team approach and tools from
the TheraDoc computerized safety surveillance and decision support
system. Healthcare providers at JDCH found that it was difficult to
track all pediatric asthma patients to ensure compliance with the
measures. In some cases, patient length of stay was only one to two
days, further complicating efforts to comply with the core
measures. The team utilized TheraDoc computer-generated alerts to
identify pediatric asthma patients based on prescription medication
and admissions data as a first step in implementing a core measure
for providing pediatric asthma home management care plans to
patients and caregivers -- resulting in a 97 percent compliance
rate with the asthma core measures. JDCH has used the TheraDoc
decision support technology since 2007 for infection prevention,
medication safety and other applications. The system automates the
collection and analysis of clinical data from a range of sources
within the hospital and alerts caregivers to clinically significant
information so that appropriate interventions can be made. The
software also helps coordinate communication among patient care
teams and hospital executives, and facilitates reporting to public
health officials and quality organizations. "We adopted the
pediatric asthma initiatives based on our desire to be at the
forefront of quality patient care," said Alice Chan, R.Ph., IT
clinical applications manager at MHS. "We were committed to
decreasing the need for readmission and achieving a high compliance
rate with the quality measures, and TheraDoc helped us streamline
the process. We are pleased that we can share our experience and
success of using information technology to help improve the quality
of patient care." According to Stanley Pestotnik, M.S., R.Ph.,
general manager, TheraDoc, Hospira, JDCH's success with these
quality initiatives illustrates the versatility of the TheraDoc
clinical surveillance platform, which provides tools to quickly
address a range of quality and patient safety challenges that arise
in healthcare every day. "We are pleased that Joe DiMaggio
Children's Hospital's outstanding accomplishments were recognized
by HIMSS," Pestotnik said. "Healthcare quality and patient safety
challenges continue to be two of the country's most critical
healthcare priorities, and we share the hospital's ongoing
commitment to improving patient safety and care through the
management of medical information." About the HIMSS "Stories of
Success!" Program The HIMSS "Stories of Success!" are designed to
highlight the fulfillment of national priorities established by the
National Priorities Partnership and The Joint Commission's National
Patient Safety Goals. Sixteen real-world and peer-reviewed case
study submissions were designated as either Tier 1 or Tier 2
finalists as part of the inaugural call for case studies. Memorial
Healthcare System was honored in the Tier 2 category. To receive a
copy of the case study, e-mail bsullivan@sullivanpr.com. About
Hospira Hospira, Inc. is a global specialty pharmaceutical and
medication delivery company dedicated to Advancing Wellness(TM). As
the world leader in specialty generic injectable pharmaceuticals,
Hospira offers one of the broadest portfolios of generic acute-care
and oncology injectables, as well as integrated infusion therapy
and medication management solutions. Through its products, Hospira
helps improve the safety, cost and productivity of patient care.
The company is headquartered in Lake Forest, Ill., and has
approximately 13,500 employees. Learn more at
http://www.hospira.com/. DATASOURCE: Hospira, Inc. CONTACT: Media,
Barbara Sullivan, +1-714-374-6174,bsullivan@sullivanpr.com, or
Tareta Adams, +1-224-212-2535, or FinancialCommunity, Karen King,
+1-224-212-2711, or Ruth Venning, +1-224-212-2774, allof Hospira,
Inc. Web Site: http://www.hospira.com/http://www.mhs.net/
Copyright
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024